These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29105342)

  • 1. Optimization and Evaluation of Antiparasitic Benzamidobenzoic Acids as Inhibitors of Kinetoplastid Hexokinase 1.
    Flaherty DP; Harris MT; Schroeder CE; Khan H; Kahney EW; Hackler AL; Patrick SL; Weiner WS; Aubé J; Sharlow ER; Morris JC; Golden JE
    ChemMedChem; 2017 Dec; 12(23):1994-2005. PubMed ID: 29105342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A target-based high throughput screen yields Trypanosoma brucei hexokinase small molecule inhibitors with antiparasitic activity.
    Sharlow ER; Lyda TA; Dodson HC; Mustata G; Morris MT; Leimgruber SS; Lee KH; Kashiwada Y; Close D; Lazo JS; Morris JC
    PLoS Negl Trop Dis; 2010 Apr; 4(4):e659. PubMed ID: 20405000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiparasitic lethality of sulfonamidebenzamides in kinetoplastids.
    Hackler A; Patrick SL; Kahney EW; Flaherty DP; Sharlow ER; Morris JC; Golden JE
    Bioorg Med Chem Lett; 2017 Feb; 27(4):755-758. PubMed ID: 28119024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-trypanosomal agent lonidamine inhibits Trypanosoma brucei hexokinase 1.
    Chambers JW; Fowler ML; Morris MT; Morris JC
    Mol Biochem Parasitol; 2008 Apr; 158(2):202-7. PubMed ID: 18262292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin, a fluorescent bioflavanoid, inhibits Trypanosoma brucei hexokinase 1.
    Dodson HC; Lyda TA; Chambers JW; Morris MT; Christensen KA; Morris JC
    Exp Parasitol; 2011 Feb; 127(2):423-8. PubMed ID: 20971104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Antiparasitic Bis-Naphthoquinone Derivatives.
    Jentzsch J; Koko WS; Al Nasr IS; Khan TA; Schobert R; Ersfeld K; Biersack B
    Chem Biodivers; 2020 Feb; 17(2):e1900597. PubMed ID: 31804031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.
    Tulloch LB; Martini VP; Iulek J; Huggan JK; Lee JH; Gibson CL; Smith TK; Suckling CJ; Hunter WN
    J Med Chem; 2010 Jan; 53(1):221-9. PubMed ID: 19916554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiparasitic activities of new lawsone Mannich bases.
    Al Nasr I; Jentzsch J; Winter I; Schobert R; Ersfeld K; Koko WS; Mujawah AAH; Khan TA; Biersack B
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900128. PubMed ID: 31536649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anti-parasitic activity of a novel quinolinone-chalcone series.
    Roussaki M; Hall B; Lima SC; da Silva AC; Wilkinson S; Detsi A
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6436-41. PubMed ID: 24119553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity.
    Di Pisa F; Landi G; Dello Iacono L; Pozzi C; Borsari C; Ferrari S; Santucci M; Santarem N; Cordeiro-da-Silva A; Moraes CB; Alcantara LM; Fontana V; Freitas-Junior LH; Gul S; Kuzikov M; Behrens B; Pöhner I; Wade RC; Costi MP; Mangani S
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28282886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of a second Trypanosoma brucei hexokinase is controlled by an 18-amino-acid C-terminal tail.
    Morris MT; DeBruin C; Yang Z; Chambers JW; Smith KS; Morris JC
    Eukaryot Cell; 2006 Dec; 5(12):2014-23. PubMed ID: 17028241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridyl benzamides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei.
    Ferrins L; Gazdik M; Rahmani R; Varghese S; Sykes ML; Jones AJ; Avery VM; White KL; Ryan E; Charman SA; Kaiser M; Bergström CA; Baell JB
    J Med Chem; 2014 Aug; 57(15):6393-402. PubMed ID: 24978605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of phenothiazine- and phenoxazine-derived chloroacetamides on Leishmania major growth and Trypanosoma brucei trypanothione reductase.
    Marcu A; Schurigt U; Müller K; Moll H; Krauth-Siegel RL; Prinz H
    Eur J Med Chem; 2016 Jan; 108():436-443. PubMed ID: 26708110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly improved antiparasitic activity after introduction of an N-benzylimidazole moiety on protein farnesyltransferase inhibitors.
    Bosc D; Mouray E; Cojean S; Franco CH; Loiseau PM; Freitas-Junior LH; Moraes CB; Grellier P; Dubois J
    Eur J Med Chem; 2016 Feb; 109():173-86. PubMed ID: 26774924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-myristoyltransferase inhibitors as new leads to treat sleeping sickness.
    Frearson JA; Brand S; McElroy SP; Cleghorn LA; Smid O; Stojanovski L; Price HP; Guther ML; Torrie LS; Robinson DA; Hallyburton I; Mpamhanga CP; Brannigan JA; Wilkinson AJ; Hodgkinson M; Hui R; Qiu W; Raimi OG; van Aalten DM; Brenk R; Gilbert IH; Read KD; Fairlamb AH; Ferguson MA; Smith DF; Wyatt PG
    Nature; 2010 Apr; 464(7289):728-32. PubMed ID: 20360736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinuclidine derivatives as potential antiparasitics.
    Cammerer SB; Jimenez C; Jones S; Gros L; Lorente SO; Rodrigues C; Rodrigues JC; Caldera A; Ruiz Perez LM; da Souza W; Kaiser M; Brun R; Urbina JA; Gonzalez Pacanowska D; Gilbert IH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4049-61. PubMed ID: 17709461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections.
    Linciano P; Pozzi C; Iacono LD; di Pisa F; Landi G; Bonucci A; Gul S; Kuzikov M; Ellinger B; Witt G; Santarem N; Baptista C; Franco C; Moraes CB; Müller W; Wittig U; Luciani R; Sesenna A; Quotadamo A; Ferrari S; Pöhner I; Cordeiro-da-Silva A; Mangani S; Costantino L; Costi MP
    J Med Chem; 2019 Apr; 62(8):3989-4012. PubMed ID: 30908048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycerol 3-phosphate alters Trypanosoma brucei hexokinase activity in response to environmental change.
    Dodson HC; Morris MT; Morris JC
    J Biol Chem; 2011 Sep; 286(38):33150-7. PubMed ID: 21813651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for antiparasitic drugs. The case of Trypanosoma brucei, the causative agent of African sleeping sickness.
    Eisenthal R; Cornish-Bowden A
    J Biol Chem; 1998 Mar; 273(10):5500-5. PubMed ID: 9488673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of N-(3-sulfamoylphenyl)amides as Trypanosoma brucei leucyl-tRNA synthetase inhibitors.
    Li Z; Xin W; Wang Q; Zhu M; Zhou H
    Eur J Med Chem; 2021 May; 217():113319. PubMed ID: 33725631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.